1-5 of 5
Paul Auer
Close
Sort by
Journal Articles

Prognostic Impact and Landscape of Mitochondrial DNA Variants in Myelodysplastic Syndromes Undergoing Allogenic Hematopoietic Cell Transplantation

Jing Dong, Christopher Staffi Buradagunta, Tao Zhang, Stephen R. Spellman, Yung-Tsi Bolon, Paul Auer, Wael Saber
Journal: Blood
Blood (2022) 140 (Supplement 1): 6930–6931.
https://doi.org/10.1182/blood-2022-159738
Published: 2022
Journal Articles

Association of Human Leukocyte Antigen Variants with Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Ben Massat, Gokul Pareek, Christopher Staffi Buradagunta, Bicky Thapa, Paul Auer, Binod Dhakal, Siegfried Janz, Parameswaran Hari, Jing Dong
Journal: Blood
Blood (2022) 140 (Supplement 1): 10063–10064.
https://doi.org/10.1182/blood-2022-160086
Published: 2022
Journal Articles

Identification of Novel Prognostic Biomarkers DDX11 and CHD1 of Allogeneic Hematopoietic Cell Transplantation Outcomes for Patients with MDS: A CIBMTR Comprehensive Genomic Screening

Tao Zhang, Paul Auer, Stephen R. Spellman, Caitrin Fretham, Yung-Tsi Bolon, Wael Saber
Journal: Blood
Blood (2021) 138 (Supplement 1): 3681.
https://doi.org/10.1182/blood-2021-153344
Published: 2021
Journal Articles

Genomic Subgroups Impact Post-Transplant Survival in Patients with Myelodysplastic Syndrome: A CIBMTR Analysis

Tao Zhang, Paul Auer, Stephen R. Spellman, Caitrin Fretham, Wael Saber, Yung-Tsi Bolon
Journal: Blood
Blood (2021) 138 (Supplement 1): 3678.
https://doi.org/10.1182/blood-2021-151621
Published: 2021
Journal Articles

Epigenomic Signatures in Myelodysplastic Syndrome Patients As Predictors of Donor Compatibility and Transplant Outcome

Wei Wang, Paul Auer, PhD, Stephen R. Spellman, MS, Karen-Sue B. Carlson, MD PhD, Aziz Nazha, MD, Martin Maiers, MS, Yung-Tsi Bolon, Wael Saber, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4557.
https://doi.org/10.1182/blood-2019-127124
Published: 2019